Drug billing: You could be supplied with Part B drugs with-out having to buy and bill for them, under a proposed rule. But this option may not be available to all practitioners at once

Article Overview

This article covers a CMS proposed rule that would let some practitioners obtain Medicare Part B drugs through a competitive bidding arrangement instead of the usual buy-and-bill process. It discusses the proposed implementation approach, enrollment timing, vendor participation, specialty and geographic phasing options, and a related claim-reporting issue for emergency drug use. The content is relevant to physicians, billing staff, oncology and other specialty practices, and anyone tracking Medicare drug payment policy changes.